| GlaxoSmithKline AG - Zyban, Retardtabletten | | 55263 | | 01 | | Zyban | | Retardtabletten | | N06AX12 | | Bupropion | | 27.12.1999 | | |
| | Composition | | bupropioni hydrochloridum 150 mg, cellulosum microcristallinum, hypromellosum, cysteini hydrochloridum monohydricum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, E 171, cera carnauba, E 172 pro compresso obducto. | | Packungsbestandteile | | Delayed release tablets | | | | | Active Agent | Dose |
|---|
| Bupropion Hydrochloride | 150 mg |
| | BAG: Active Agent | Dose |
|---|
| Bupropion Hydrochloride | 150 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Cellulosum Microcristallinum | | | | Cera Carnauba | | | | Cystein Hydrochloride Monohydrate | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | |
| |
| |
|
